I have a VERY large position in CTIX, so I am absolutely not in any way trying to bash the stock. (I was accused of this on the other board when people were trying to live in their castles in the air.)

It is entirely possible that these first, VERY EARLY, tests may show NO activity. The dose may be too low to trigger it. Be prepared for a "meh" report. If they say that first results did NOT reveal activity, the stock is going to be torpedoed, at least briefly. If you (unlike me) still have some money left, and IF that happens, it is a buying opportunity.

Unlike all of you, I am NOT happy that they are doing the test this early, when such low doses have been given. Think about when you have a bad headache, and you take one aspirin or tylenol or ibuprofen, and it doesn't help. Then you take a second one, and poof! headache goes away. Kevetrin may NOT have reached the level of the critical dose yet. That does NOT mean it doesn't work.... in the proper dose.